Home | Welcome to Contract Pharma   
Last Updated Sunday, May 19 2013
Print RSS Feed

Breaking News

Related Searches: Collaborations & Alliances •
Lilly, Ambrx Collaborate on Bio-Discovery

December 17, 2007
Lilly and Ambrx Inc. have entered into a collaboration to discover and develop novel treatments in several therapeutic areas, including metabolic diseases, central nervous system disorders and other diseases. The collaboration will apply Ambrx's uniq…  Read More »
Amgen, Oxford Genome Sciences Sign Onco-Pact

December 17, 2007
Amgen and Oxford Genome Sciences (UK) have entered into a strategic collaboration to discover, develop and commercialize novel therapeutic antibodies for the treatment of cancer. This collaboration will enable OGS to  strengthen its pipeline of…  Read More »
Patheon To Sell One PR Site

December 14, 2007
Patheon announced that it plans to sell its facility in Carolina, PR, while retaining two other sites in Caguas and Manati. The announcement came during the company's 4Q07 financial statement. The quarter ended October 31. The Carolina site is a 2…  Read More »
Neurocrine Restructures After FDA Letter

December 14, 2007
Neurocrine Biosciences announced that it will lay off approximately 130 employees at its San Diego campus, as a part of its restructuring program to prioritize its R&D programs and associated costs and expenses after an FDA delay on insomnia trea…  Read More »
GSK Exercises Exelixis Option

December 14, 2007
GlaxoSmithKline has exercised its option to exclusively license XL880 from Exelixis for further development and commercialization. XL880 is a small molecule compound currently being evaluated in Phase II trials in patients with papillary renal cell c…  Read More »
No Buyer for Biogen Idec

December 13, 2007
The board of directors at Biogen Idec have elected to keep the company independent, after a two-month flirtation with selling out to a larger company. The company announced that it did not receive "any definitive offers" for an acquisition.…  Read More »
Merck Withdraws Vaccines on Sterility Fears

December 13, 2007
Merck has initiated a voluntary recall of 11 lots of its Haemophilus influenzae type B vaccine, PEDVAXHIB, and two lots of its combination Haemophilus influenzae type B/ hepatitis B vaccine, COMVAX . The recall is specific to these 13 lots and does n…  Read More »
Novartis Restructures, To Fire 2,500

December 13, 2007
Novartis has announced a restructuring plan called, "Forward," to reduce costs and improve efficiencies. According to a company statement, the plan "is expected to simplify working processes and decision making by eliminating layers, c…  Read More »
Geron Gains Merck Milestone for Cancer Vax IND

December 12, 2007
Merck has filed an IND with the FDA for a cancer vaccine candidate that targets telomerase. Merck is developing the vaccine under a July, 2005 Research, Development and Commercialization License Agreement with Geron Corp., which provided exclusive wo…  Read More »
West To Restructure Tech Group

December 12, 2007
West Pharmaceutical Services will implement a restructuring plan for its Tech Group segment. The restructuring "addresses the recent reduction in business due to changes in customers' marketing plans by reducing the operating costs and increasin…  Read More »
BMS, Gilead Agree on Atripla

December 11, 2007
Bristol-Myers Squibb and Gilead Sciences have formed an agreement to commercialize Atripla in Europe for the treatment of virologically suppressed adults with HIV-1 infection. If approved in the EU, Atripla would represent that region's the first and…  Read More »
Quintiles Transnational

December 11, 2007
John Goodacre has been named executive vice president and general counsel of Quintiles Transnational Corp. Previously senior vice president, Global Risk Management and Quality Assurance, Mr. Goodacre joined Quintiles in 1998 as vice president, Europe…  Read More »
Gene Logics Sells Assets, Renames

December 11, 2007
Shareholders of Gene Logic have approved the sale of the company's genomics assets to Ocimum Biosolutions and the subsequent renaming of the company as Ore Pharmaceuticals. The genomics sale is expected to close later this week and will effectively l…  Read More »
GSK, OncoMed Form Cancer Collaboration

December 10, 2007
GlaxoSmithKline and OncoMed Pharmaceuticals have formed a strategic alliance to discover, develop and market novel antibody therapeutics to target cancer stem cells. These cells are believed to play a key role in the establishment, metastasis and rec…  Read More »
Eisai To Acquire MGI Pharma

December 10, 2007
Eisai Co., Ltd. will acquire MGI Pharma for approximately $3.9 billion in an all-cash transaction. The acquisition has been unanimously approved by MGI's board; it is expected to occur by means of a tender offer followed by a cash merger, is subject…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: